SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-21-009539
Filing Date
2021-10-19
Accepted
2021-10-19 17:56:49
Documents
2
Period of Report
2021-10-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 3353
2 kantoffpoa.txt EX-24 3840
  Complete submission text file 0001179110-21-009539.txt   8669
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Kantoff Philip W. (Reporting) CIK: 0001866025 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40654 | Film No.: 211332112